BIODESIX INC — Director's Dealing 2025

Sep 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-09-17

Reporting Person: SCHULER JACK W (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-17	Common Stock	P	15317	$6.0437	Acquired	1235644	Indirect
2025-09-18	Common Stock	P	3056	$6.1695	Acquired	1238700	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	750000	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.825 to $6.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.125 to $6.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F5: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2025 GRAT.